aluates Reports

$ 0.0

Automative

Global Novel Drug Delivery Systems Market Research Report 2026

Published Date: 2026-01-16

Report Code: QYRE-Auto-30X82

Global Novel Drug Delivery Systems Market Size Status and Forecast 2022

BUY CHAPTERS

Global Novel Drug Delivery Systems Market Research Report 2026

Code: QYRE-Auto-30X82

Report

2026-01-16

Pages:142

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

TEVA

Celgene

Sanofi

Merck

Johnson & Johnson

Takeda

Gilead Sciences

Pfizer Inc

Dr. Reddy

Samyang Biopharmaceuticals

Tolmar

Astellas

AMAG Pharmaceuticals

Astrazeneca plc

AbbVie

Bausch & Lomb

TWi Pharmaceuticals

Aspen

Union Chimique Belge

Acrotech Biopharma

UCB (Union Chimique Belge)

Roche

Johnson & Johnson

Bausch & Lomb

Johnson & Johnson

Bausch & Lomb

Novel Drug Delivery Systems Market Size

The global Novel Drug Delivery Systems market was valued at US$ 25510 million in 2025 and is anticipated to reach US$ 28660 million by 2032, at a CAGR of 1.7% from 2026 to 2032.

Novel Drug Delivery Systems Market

Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.

Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.

Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%.

North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent.

In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc.

This report delivers a comprehensive overview of the global Novel Drug Delivery Systems market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Novel Drug Delivery Systems. The Novel Drug Delivery Systems market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Novel Drug Delivery Systems market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Novel Drug Delivery Systems manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Novel Drug Delivery Systems Market Report

Report Metric	Details
Report Name	Novel Drug Delivery Systems Market
Accounted market size in 2025	US$ 25510 million
Forecasted market size in 2032	US$ 28660 million
CAGR	1.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Liposomes PEGylated Proteins & Polypeptides Polymer Nanoparticle Protein–drug Conjugates Others
Segment by Application	Hospitals & Clinic Cancer Treatment Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, Bausch&Lomb, Samyang Biopharmaceuticals, Johnson & Johnson, TOLMAR, Astellas, AMAG Pharmaceuticals, AbbVie, Dr Reddy, AstraZeneca, Aspen, Acrotech Biopharma, TWi Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Novel Drug Delivery Systems companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Novel Drug Delivery Systems Market growing?

Ans: The Novel Drug Delivery Systems Market witnessing a CAGR of 1.7% during the forecast period 2026-2032.

What is the Novel Drug Delivery Systems Market size in 2032?

Ans: The Novel Drug Delivery Systems Market size in 2032 will be US$ 28660 million.

What is the market share of major companies in Novel Drug Delivery Systems Market?

Ans: Global top four manufacturers hold a share over 40%.

What is the Novel Drug Delivery Systems Market share by type?

Ans: In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%.

Who are the main players in the Novel Drug Delivery Systems Market report?

Ans: The main players in the Novel Drug Delivery Systems Market are Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, Bausch&Lomb, Samyang Biopharmaceuticals, Johnson & Johnson, TOLMAR, Astellas, AMAG Pharmaceuticals, AbbVie, Dr Reddy, AstraZeneca, Aspen, Acrotech Biopharma, TWi Pharmaceuticals

What are the Application segmentation covered in the Novel Drug Delivery Systems Market report?

Ans: The Applications covered in the Novel Drug Delivery Systems Market report are Hospitals & Clinic, Cancer Treatment Centers, Others

What are the Type segmentation covered in the Novel Drug Delivery Systems Market report?

Ans: The Types covered in the Novel Drug Delivery Systems Market report are Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Liposomes

1.2.3 PEGylated Proteins & Polypeptides

1.2.4 Polymer Nanoparticle

1.2.5 Protein–drug Conjugates

1.2.6 Others

1.3 Market by Application

1.3.1 Global Novel Drug Delivery Systems Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospitals & Clinic

1.3.3 Cancer Treatment Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Novel Drug Delivery Systems Market Perspective (2021–2032)

2.2 Global Novel Drug Delivery Systems Growth Trends by Region

2.2.1 Global Novel Drug Delivery Systems Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Novel Drug Delivery Systems Historic Market Size by Region (2021–2026)

2.2.3 Novel Drug Delivery Systems Forecasted Market Size by Region (2027–2032)

2.3 Novel Drug Delivery Systems Market Dynamics

2.3.1 Novel Drug Delivery Systems Industry Trends

2.3.2 Novel Drug Delivery Systems Market Drivers

2.3.3 Novel Drug Delivery Systems Market Challenges

2.3.4 Novel Drug Delivery Systems Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Novel Drug Delivery Systems Players by Revenue

3.1.1 Global Top Novel Drug Delivery Systems Players by Revenue (2021–2026)

3.1.2 Global Novel Drug Delivery Systems Revenue Market Share by Players (2021–2026)

3.2 Global Top Novel Drug Delivery Systems Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Novel Drug Delivery Systems Revenue

3.4 Global Novel Drug Delivery Systems Market Concentration Ratio

3.4.1 Global Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Novel Drug Delivery Systems Revenue in 2025

3.5 Global Key Players of Novel Drug Delivery Systems Head Offices and Areas Served

3.6 Global Key Players of Novel Drug Delivery Systems, Products and Applications

3.7 Global Key Players of Novel Drug Delivery Systems, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Novel Drug Delivery Systems Breakdown Data by Type

4.1 Global Novel Drug Delivery Systems Historic Market Size by Type (2021–2026)

4.2 Global Novel Drug Delivery Systems Forecasted Market Size by Type (2027–2032)

5 Novel Drug Delivery Systems Breakdown Data by Application

5.1 Global Novel Drug Delivery Systems Historic Market Size by Application (2021–2026)

5.2 Global Novel Drug Delivery Systems Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Novel Drug Delivery Systems Market Size (2021–2032)

6.2 North America Novel Drug Delivery Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Novel Drug Delivery Systems Market Size by Country (2021–2026)

6.4 North America Novel Drug Delivery Systems Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Novel Drug Delivery Systems Market Size (2021–2032)

7.2 Europe Novel Drug Delivery Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Novel Drug Delivery Systems Market Size by Country (2021–2026)

7.4 Europe Novel Drug Delivery Systems Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Novel Drug Delivery Systems Market Size (2021–2032)

8.2 Asia-Pacific Novel Drug Delivery Systems Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2021–2026)

8.4 Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Novel Drug Delivery Systems Market Size (2021–2032)

9.2 Latin America Novel Drug Delivery Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Novel Drug Delivery Systems Market Size by Country (2021–2026)

9.4 Latin America Novel Drug Delivery Systems Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Novel Drug Delivery Systems Market Size (2021–2032)

10.2 Middle East & Africa Novel Drug Delivery Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2021–2026)

10.4 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Novel Drug Delivery Systems Introduction

11.1.4 Amgen Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.1.5 Amgen Recent Development

11.2 Teva

11.2.1 Teva Company Details

11.2.2 Teva Business Overview

11.2.3 Teva Novel Drug Delivery Systems Introduction

11.2.4 Teva Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.2.5 Teva Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Novel Drug Delivery Systems Introduction

11.3.4 Roche Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.3.5 Roche Recent Development

11.4 UCB (Union Chimique Belge)

11.4.1 UCB (Union Chimique Belge) Company Details

11.4.2 UCB (Union Chimique Belge) Business Overview

11.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Introduction

11.4.4 UCB (Union Chimique Belge) Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.4.5 UCB (Union Chimique Belge) Recent Development

11.5 Celgene

11.5.1 Celgene Company Details

11.5.2 Celgene Business Overview

11.5.3 Celgene Novel Drug Delivery Systems Introduction

11.5.4 Celgene Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.5.5 Celgene Recent Development

11.6 Merck

11.6.1 Merck Company Details

11.6.2 Merck Business Overview

11.6.3 Merck Novel Drug Delivery Systems Introduction

11.6.4 Merck Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.6.5 Merck Recent Development

11.7 Gilead Sciences

11.7.1 Gilead Sciences Company Details

11.7.2 Gilead Sciences Business Overview

11.7.3 Gilead Sciences Novel Drug Delivery Systems Introduction

11.7.4 Gilead Sciences Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.7.5 Gilead Sciences Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Novel Drug Delivery Systems Introduction

11.8.4 Sanofi Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.8.5 Sanofi Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Novel Drug Delivery Systems Introduction

11.9.4 Pfizer Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.9.5 Pfizer Recent Development

11.10 Takeda

11.10.1 Takeda Company Details

11.10.2 Takeda Business Overview

11.10.3 Takeda Novel Drug Delivery Systems Introduction

11.10.4 Takeda Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.10.5 Takeda Recent Development

11.11 Bausch&Lomb

11.11.1 Bausch&Lomb Company Details

11.11.2 Bausch&Lomb Business Overview

11.11.3 Bausch&Lomb Novel Drug Delivery Systems Introduction

11.11.4 Bausch&Lomb Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.11.5 Bausch&Lomb Recent Development

11.12 Samyang Biopharmaceuticals

11.12.1 Samyang Biopharmaceuticals Company Details

11.12.2 Samyang Biopharmaceuticals Business Overview

11.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Introduction

11.12.4 Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.12.5 Samyang Biopharmaceuticals Recent Development

11.13 Johnson & Johnson

11.13.1 Johnson & Johnson Company Details

11.13.2 Johnson & Johnson Business Overview

11.13.3 Johnson & Johnson Novel Drug Delivery Systems Introduction

11.13.4 Johnson & Johnson Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.13.5 Johnson & Johnson Recent Development

11.14 TOLMAR

11.14.1 TOLMAR Company Details

11.14.2 TOLMAR Business Overview

11.14.3 TOLMAR Novel Drug Delivery Systems Introduction

11.14.4 TOLMAR Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.14.5 TOLMAR Recent Development

11.15 Astellas

11.15.1 Astellas Company Details

11.15.2 Astellas Business Overview

11.15.3 Astellas Novel Drug Delivery Systems Introduction

11.15.4 Astellas Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.15.5 Astellas Recent Development

11.16 AMAG Pharmaceuticals

11.16.1 AMAG Pharmaceuticals Company Details

11.16.2 AMAG Pharmaceuticals Business Overview

11.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Introduction

11.16.4 AMAG Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.16.5 AMAG Pharmaceuticals Recent Development

11.17 AbbVie

11.17.1 AbbVie Company Details

11.17.2 AbbVie Business Overview

11.17.3 AbbVie Novel Drug Delivery Systems Introduction

11.17.4 AbbVie Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.17.5 AbbVie Recent Development

11.18 Dr Reddy

11.18.1 Dr Reddy Company Details

11.18.2 Dr Reddy Business Overview

11.18.3 Dr Reddy Novel Drug Delivery Systems Introduction

11.18.4 Dr Reddy Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.18.5 Dr Reddy Recent Development

11.19 AstraZeneca

11.19.1 AstraZeneca Company Details

11.19.2 AstraZeneca Business Overview

11.19.3 AstraZeneca Novel Drug Delivery Systems Introduction

11.19.4 AstraZeneca Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.19.5 AstraZeneca Recent Development

11.20 Aspen

11.20.1 Aspen Company Details

11.20.2 Aspen Business Overview

11.20.3 Aspen Novel Drug Delivery Systems Introduction

11.20.4 Aspen Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.20.5 Aspen Recent Development

11.21 Acrotech Biopharma

11.21.1 Acrotech Biopharma Company Details

11.21.2 Acrotech Biopharma Business Overview

11.21.3 Acrotech Biopharma Novel Drug Delivery Systems Introduction

11.21.4 Acrotech Biopharma Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.21.5 Acrotech Biopharma Recent Development

11.22 TWi Pharmaceuticals

11.22.1 TWi Pharmaceuticals Company Details

11.22.2 TWi Pharmaceuticals Business Overview

11.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Introduction

11.22.4 TWi Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2021–2026)

11.22.5 TWi Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

TEVA

Celgene

Sanofi

Merck

Johnson & Johnson

Takeda

Gilead Sciences

Pfizer Inc

Dr. Reddy

Samyang Biopharmaceuticals

Tolmar

Astellas

AMAG Pharmaceuticals

Astrazeneca plc

AbbVie

Bausch & Lomb

TWi Pharmaceuticals

Aspen

Union Chimique Belge

Acrotech Biopharma

UCB (Union Chimique Belge)

Roche

Johnson & Johnson

Bausch & Lomb

Johnson & Johnson

Bausch & Lomb

List of Tables

Table 1. Global Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Liposomes

Table 3. Key Players of PEGylated Proteins & Polypeptides

Table 4. Key Players of Polymer Nanoparticle

Table 5. Key Players of Protein–drug Conjugates

Table 6. Key Players of Others

Table 7. Global Novel Drug Delivery Systems Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Novel Drug Delivery Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Novel Drug Delivery Systems Market Size by Region (US$ Million), 2021–2026

Table 10. Global Novel Drug Delivery Systems Market Share by Region (2021–2026)

Table 11. Global Novel Drug Delivery Systems Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Novel Drug Delivery Systems Market Share by Region (2027–2032)

Table 13. Novel Drug Delivery Systems Market Trends

Table 14. Novel Drug Delivery Systems Market Drivers

Table 15. Novel Drug Delivery Systems Market Challenges

Table 16. Novel Drug Delivery Systems Market Restraints

Table 17. Global Novel Drug Delivery Systems Revenue by Players (US$ Million), 2021–2026

Table 18. Global Novel Drug Delivery Systems Market Share by Players (2021–2026)

Table 19. Global Top Novel Drug Delivery Systems Players by Tier (Tier 1, Tier 2, and Tier 3), based on Novel Drug Delivery Systems Revenue, 2025

Table 20. Ranking of Global Top Novel Drug Delivery Systems Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Novel Drug Delivery Systems Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Novel Drug Delivery Systems, Headquarters and Area Served

Table 23. Global Key Players of Novel Drug Delivery Systems, Products and Applications

Table 24. Global Key Players of Novel Drug Delivery Systems, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Novel Drug Delivery Systems Market Size by Type (US$ Million), 2021–2026

Table 27. Global Novel Drug Delivery Systems Revenue Market Share by Type (2021–2026)

Table 28. Global Novel Drug Delivery Systems Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Novel Drug Delivery Systems Revenue Market Share by Type (2027–2032)

Table 30. Global Novel Drug Delivery Systems Market Size by Application (US$ Million), 2021–2026

Table 31. Global Novel Drug Delivery Systems Revenue Market Share by Application (2021–2026)

Table 32. Global Novel Drug Delivery Systems Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Novel Drug Delivery Systems Revenue Market Share by Application (2027–2032)

Table 34. North America Novel Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Novel Drug Delivery Systems Market Size by Country (US$ Million), 2021–2026

Table 36. North America Novel Drug Delivery Systems Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Novel Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Novel Drug Delivery Systems Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Novel Drug Delivery Systems Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Novel Drug Delivery Systems Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Novel Drug Delivery Systems Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Novel Drug Delivery Systems Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Novel Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Novel Drug Delivery Systems Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Novel Drug Delivery Systems Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Novel Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Novel Drug Delivery Systems Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Novel Drug Delivery Systems Market Size by Country (US$ Million), 2027–2032

Table 49. Amgen Company Details

Table 50. Amgen Business Overview

Table 51. Amgen Novel Drug Delivery Systems Product

Table 52. Amgen Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 53. Amgen Recent Development

Table 54. Teva Company Details

Table 55. Teva Business Overview

Table 56. Teva Novel Drug Delivery Systems Product

Table 57. Teva Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 58. Teva Recent Development

Table 59. Roche Company Details

Table 60. Roche Business Overview

Table 61. Roche Novel Drug Delivery Systems Product

Table 62. Roche Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 63. Roche Recent Development

Table 64. UCB (Union Chimique Belge) Company Details

Table 65. UCB (Union Chimique Belge) Business Overview

Table 66. UCB (Union Chimique Belge) Novel Drug Delivery Systems Product

Table 67. UCB (Union Chimique Belge) Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 68. UCB (Union Chimique Belge) Recent Development

Table 69. Celgene Company Details

Table 70. Celgene Business Overview

Table 71. Celgene Novel Drug Delivery Systems Product

Table 72. Celgene Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 73. Celgene Recent Development

Table 74. Merck Company Details

Table 75. Merck Business Overview

Table 76. Merck Novel Drug Delivery Systems Product

Table 77. Merck Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 78. Merck Recent Development

Table 79. Gilead Sciences Company Details

Table 80. Gilead Sciences Business Overview

Table 81. Gilead Sciences Novel Drug Delivery Systems Product

Table 82. Gilead Sciences Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 83. Gilead Sciences Recent Development

Table 84. Sanofi Company Details

Table 85. Sanofi Business Overview

Table 86. Sanofi Novel Drug Delivery Systems Product

Table 87. Sanofi Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 88. Sanofi Recent Development

Table 89. Pfizer Company Details

Table 90. Pfizer Business Overview

Table 91. Pfizer Novel Drug Delivery Systems Product

Table 92. Pfizer Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 93. Pfizer Recent Development

Table 94. Takeda Company Details

Table 95. Takeda Business Overview

Table 96. Takeda Novel Drug Delivery Systems Product

Table 97. Takeda Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 98. Takeda Recent Development

Table 99. Bausch&Lomb Company Details

Table 100. Bausch&Lomb Business Overview

Table 101. Bausch&Lomb Novel Drug Delivery Systems Product

Table 102. Bausch&Lomb Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 103. Bausch&Lomb Recent Development

Table 104. Samyang Biopharmaceuticals Company Details

Table 105. Samyang Biopharmaceuticals Business Overview

Table 106. Samyang Biopharmaceuticals Novel Drug Delivery Systems Product

Table 107. Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 108. Samyang Biopharmaceuticals Recent Development

Table 109. Johnson & Johnson Company Details

Table 110. Johnson & Johnson Business Overview

Table 111. Johnson & Johnson Novel Drug Delivery Systems Product

Table 112. Johnson & Johnson Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 113. Johnson & Johnson Recent Development

Table 114. TOLMAR Company Details

Table 115. TOLMAR Business Overview

Table 116. TOLMAR Novel Drug Delivery Systems Product

Table 117. TOLMAR Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 118. TOLMAR Recent Development

Table 119. Astellas Company Details

Table 120. Astellas Business Overview

Table 121. Astellas Novel Drug Delivery Systems Product

Table 122. Astellas Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 123. Astellas Recent Development

Table 124. AMAG Pharmaceuticals Company Details

Table 125. AMAG Pharmaceuticals Business Overview

Table 126. AMAG Pharmaceuticals Novel Drug Delivery Systems Product

Table 127. AMAG Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 128. AMAG Pharmaceuticals Recent Development

Table 129. AbbVie Company Details

Table 130. AbbVie Business Overview

Table 131. AbbVie Novel Drug Delivery Systems Product

Table 132. AbbVie Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 133. AbbVie Recent Development

Table 134. Dr Reddy Company Details

Table 135. Dr Reddy Business Overview

Table 136. Dr Reddy Novel Drug Delivery Systems Product

Table 137. Dr Reddy Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 138. Dr Reddy Recent Development

Table 139. AstraZeneca Company Details

Table 140. AstraZeneca Business Overview

Table 141. AstraZeneca Novel Drug Delivery Systems Product

Table 142. AstraZeneca Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 143. AstraZeneca Recent Development

Table 144. Aspen Company Details

Table 145. Aspen Business Overview

Table 146. Aspen Novel Drug Delivery Systems Product

Table 147. Aspen Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 148. Aspen Recent Development

Table 149. Acrotech Biopharma Company Details

Table 150. Acrotech Biopharma Business Overview

Table 151. Acrotech Biopharma Novel Drug Delivery Systems Product

Table 152. Acrotech Biopharma Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 153. Acrotech Biopharma Recent Development

Table 154. TWi Pharmaceuticals Company Details

Table 155. TWi Pharmaceuticals Business Overview

Table 156. TWi Pharmaceuticals Novel Drug Delivery Systems Product

Table 157. TWi Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (US$ Million), 2021–2026

Table 158. TWi Pharmaceuticals Recent Development

Table 159. Research Programs/Design for This Report

Table 160. Key Data Information from Secondary Sources

Table 161. Key Data Information from Primary Sources

Table 162. Authors List of This Report

List of Figures

Figure 1. Novel Drug Delivery Systems Picture

Figure 2. Global Novel Drug Delivery Systems Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Novel Drug Delivery Systems Market Share by Type: 2025 vs 2032

Figure 4. Liposomes Features

Figure 5. PEGylated Proteins & Polypeptides Features

Figure 6. Polymer Nanoparticle Features

Figure 7. Protein–drug Conjugates Features

Figure 8. Others Features

Figure 9. Global Novel Drug Delivery Systems Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Novel Drug Delivery Systems Market Share by Application: 2025 vs 2032

Figure 11. Hospitals & Clinic Case Studies

Figure 12. Cancer Treatment Centers Case Studies

Figure 13. Others Case Studies

Figure 14. Novel Drug Delivery Systems Report Years Considered

Figure 15. Global Novel Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global Novel Drug Delivery Systems Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Novel Drug Delivery Systems Market Share by Region: 2025 vs 2032

Figure 18. Global Novel Drug Delivery Systems Market Share by Players in 2025

Figure 19. Global Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Novel Drug Delivery Systems Revenue in 2025

Figure 21. North America Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America Novel Drug Delivery Systems Market Share by Country (2021–2032)

Figure 23. United States Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Novel Drug Delivery Systems Market Share by Country (2021–2032)

Figure 27. Germany Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Novel Drug Delivery Systems Market Share by Region (2021–2032)

Figure 35. China Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Novel Drug Delivery Systems Market Share by Country (2021–2032)

Figure 43. Mexico Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Novel Drug Delivery Systems Market Share by Country (2021–2032)

Figure 47. Israel Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE Novel Drug Delivery Systems Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Amgen Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 51. Teva Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 52. Roche Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 53. UCB (Union Chimique Belge) Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 54. Celgene Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 55. Merck Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 56. Gilead Sciences Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 57. Sanofi Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 58. Pfizer Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 59. Takeda Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 60. Bausch&Lomb Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 61. Samyang Biopharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 62. Johnson & Johnson Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 63. TOLMAR Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 64. Astellas Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 65. AMAG Pharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 66. AbbVie Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 67. Dr Reddy Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 68. AstraZeneca Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 69. Aspen Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 70. Acrotech Biopharma Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 71. TWi Pharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2021–2026)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Nanotechnology based Drug Delivery Systems Market Research Report 2024

Global Nano based Drug Delivery System Market Research Report 2024

Global Targeted Drug Delivery System Market Research Report 2025

Global Nanotechnology in Targeted Drug Delivery Market Research Report 2024

Global Pharmaceutical Drug Delivery Technologies Market Insights Forecast to 2030

Global Pharmaceutical Drug Delivery Devices Market Insights Forecast to 2030

Global Nanoparticle Mediated Delivery Market Research Report 2025

Global Nanoparticle Drug Delivery System Market Research Report 2024

Global Transdermal Drug Delivery System Market Insights Forecast to 2030

Global Oral Mucosal Drug Delivery System Market Research Report 2024

Peptide Based Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non biodegradable Implantable Drug Delivery System Market Research Report 2024

Global Pharmaceutics and Novel Drug Delivery Systems Market Insights Forecast to 2030

Novel Vaccine Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Next Generation Diabetes Therapy and Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nucleic Acid Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Soft Implantable Drug Delivery System Market Research Report 2024

Global Delivery Catheter System Market Research Report 2024

Smart Drug Delivery Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions